Concepedia

Amy E. Stewart

AE

Statistics

Publications

1

Citations

30

H-Index

1

Active since

2024

Affiliations

Xalud Therapeutics (United States)(Current)

Amy E. Stewart is an author at Xalud Therapeutics (United States) specializing in molecular oncology, intrinsic radiosensitivity, and parp inhibitor sensitivity.

ORCID

Publications per year

2024–2024

1

Publications

1

A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors

Tona M. Gilmer, Chun-Hsiang Lai, Kexiao Guo et al. · Molecular Cancer Therapeutics · 2024 · 30 citations · Full text

, , +16

1–1 of 1